ABT vs SD · P/E 25, rev $44.33B vs P/E 6.9, rev $125.3M
Abbott Laboratories (ABT) versus SandRidge Energy Inc (SD) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
SandRidge Energy Inc (SD) is a oil & gas e&p company listed on NYSE.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported SD revenue for 2024-12-31 was $125.3M. Net income was $63.0M. Revenue was down 15.7% from 2023-12-31 to 2024-12-31. SD currently screens at market cap $522.0M and trailing P/E 6.9.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. SD currently screens at market cap $522.0M and trailing P/E 6.9.
Not investment advice. Open the ABT and SD stock pages for the full models.
Not investment advice.